Ratings
0
Nobody has rated this yet. Be the first!
Works
2
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients
